134 related articles for article (PubMed ID: 15750399)
1. Generic antiretroviral efficacy in AIDS-associated Kaposi's sarcoma in sub-Saharan Africa.
Mosam A; Cassol E; Page T; Bodasing U; Cassol S; Dawood H; Friedland GH; Scadden DT; Aboobaker J; Jordaan JP; Lalloo UG; Esterhuizen TM; Coovadia HM
AIDS; 2005 Mar; 19(4):441-3. PubMed ID: 15750399
[TBL] [Abstract][Full Text] [Related]
2. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
[TBL] [Abstract][Full Text] [Related]
3. Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.
Bihl F; Berger C; Chisholm JV; Henry LM; Bertisch B; Trojan A; Nadal D; Speck RF; Flepp M; Brander C; Mueller NJ;
AIDS; 2009 Sep; 23(14):1918-22. PubMed ID: 19609199
[TBL] [Abstract][Full Text] [Related]
4. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract][Full Text] [Related]
5. HIV/AIDS-associated Kaposi's sarcoma with multiple skin-mucosal disseminations following ultraviolet (puva) photochemotherapy.
Popivanova NI; Chudomirova KN; Baltadzhiev IG; Abadjieva TI
Folia Med (Plovdiv); 2010; 52(3):56-61. PubMed ID: 21053674
[TBL] [Abstract][Full Text] [Related]
6. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma in a nonadherent HAART patient.
Ball SC
AIDS Read; 1999; 9(3):170, 173-4. PubMed ID: 12728902
[No Abstract] [Full Text] [Related]
9. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
Noy A; Scadden DT; Lee J; Dezube BJ; Aboulafia D; Tulpule A; Walmsley S; Gill P
J Clin Oncol; 2005 Feb; 23(5):990-8. PubMed ID: 15598977
[TBL] [Abstract][Full Text] [Related]
10. Regression of invasive AIDS-related Kaposi's sarcoma following antiretroviral therapy.
Parra R; Leal M; Delgado J; Macías J; Rubio A; Gómez F; Soriano V; Sanchez-Quijano A; Pineda JA; Lissen E
Clin Infect Dis; 1998 Jan; 26(1):218-9. PubMed ID: 9455557
[No Abstract] [Full Text] [Related]
11. Management of AIDS-related Kaposi's sarcoma.
Di Lorenzo G; Konstantinopoulos PA; Pantanowitz L; Di Trolio R; De Placido S; Dezube BJ
Lancet Oncol; 2007 Feb; 8(2):167-76. PubMed ID: 17267331
[TBL] [Abstract][Full Text] [Related]
12. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma.
Krown SE
J Clin Oncol; 2004 Feb; 22(3):399-402. PubMed ID: 14752065
[No Abstract] [Full Text] [Related]
13. Epidemiology of Kaposi's sarcoma in sub-Saharan Africa.
Motlhale M; Sitas F; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Muchengeti M; Waterboer T; Mathew CG; Newton R; Singh E
Cancer Epidemiol; 2022 Jun; 78():102167. PubMed ID: 35504064
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma in sub-Saharan Africa: a current perspective.
Mosam A; Aboobaker J; Shaik F
Curr Opin Infect Dis; 2010 Apr; 23(2):119-23. PubMed ID: 19996745
[TBL] [Abstract][Full Text] [Related]
15. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
Dezube BJ
Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
[TBL] [Abstract][Full Text] [Related]
16. AIDS-related Kaposi's sarcoma in a patient with a normal CD4 count.
Power DG; Mulholland PJ; O'Byrne KJ
Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):97. PubMed ID: 17954026
[No Abstract] [Full Text] [Related]
17. HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
Chien CV
PLoS One; 2007 Mar; 2(3):e278. PubMed ID: 17372625
[TBL] [Abstract][Full Text] [Related]
18. [Influence of highly active antiretroviral therapy on the evolution of AIDS-associated Kaposi's sarcoma].
Mercè Alsina M ; Bulla F; Conill C; Mallolas J; Bernardo Pérez-Cuevas J ; Lecha M
Med Clin (Barc); 2000 Dec; 115(19):736-7. PubMed ID: 11141440
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.
Laurent C; Kouanfack C; Koulla-Shiro S; Nkoué N; Bourgeois A; Calmy A; Lactuock B; Nzeusseu V; Mougnutou R; Peytavin G; Liégeois F; Nerrienet E; Tardy M; Peeters M; Andrieux-Meyer I; Zekeng L; Kazatchkine M; Mpoudi-Ngolé E; Delaporte E
Lancet; 2004 Jul 3-9; 364(9428):29-34. PubMed ID: 15234853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
